Is BCTXZ or BFRG more undervalued in 2026?

CirclFi compares BriaCell Therapeutics Corp. War (BCTXZ) and Bullfrog AI Holdings, Inc. (BFRG) using 13 institutional-grade valuation models. BCTXZ has a Quality of Company score of 4.4/10 while BFRG scores 5.5/10.

Which is a better buy — BCTXZ or BFRG?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do BCTXZ and BFRG valuations compare?

BCTXZ at $0.08 and BFRG at $0.76 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

BCTXZ vs BFRG Valuation Comparison 2026 — Intrinsic Value Analysis

BCTXZ

Pharmaceutical Preparations

BriaCell Therapeutics Corp. War

Quality

4.4

out of 10

Value Trap

SAFE

Price

$0.08

Last close

Models

1/13

Active

BFRG

Pharmaceutical Preparations

Bullfrog AI Holdings, Inc.

Quality

5.5

out of 10

Value Trap

SAFE

Price

$0.76

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	BCTXZ Fair Value	BCTXZ Upside	BFRG Fair Value	BFRG Upside
Bayesian DCF	Intrinsic	—	—	$0.23	-69.1%
Earnings Power Value	Intrinsic	—	—	$0.11	-84.5%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.31	+227.6%	$0.01	-98.6%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for BCTXZ vs BFRG — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BCTXZ vs BFRG — Which Stock Is More Undervalued?

BFRG scores higher with a 5.5/10 quality rating vs BCTXZ's 4.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing BriaCell Therapeutics Corp. War (BCTXZ) and Bullfrog AI Holdings, Inc. (BFRG) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BCTXZ currently trades at $0.08 with a QOC of 4.4/10, while BFRG trades at $0.76 with a QOC of 5.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).